UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

Cancer, 2014-02, Vol.120 (3), p.344-351

2014

Volltextzugriff (PDF)

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study

Gynecologic oncology, 2016-02, Vol.140 (2), p.204-209

2016

Volltextzugriff (PDF)

A phase I study of sequential ipilimumab in the definitive treatment of node positive cervical cancer: GOG 9929

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.5526-5526

2017

Volltextzugriff (PDF)

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

The American journal of geriatric pharmacotherapy, 2005-12, Vol.3 (4), p.218-228

2005

Volltextzugriff (PDF)

Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537–541]

Gynecologic oncology, 2014-12, Vol.135 (3), p.624-624

2014

Volltextzugriff (PDF)

Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome

Diabetes & vascular disease research, 2006-09, Vol.3 (2), p.93-102

2006

Volltextzugriff (PDF)

A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients

Clinical lymphoma, myeloma and leukemia, 2013-09, Vol.13, p.S380-S380

2013

Volltextzugriff (PDF)

Corrigendum to “A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study” [Gynecol. Oncol. 116 (2010)]

Gynecologic oncology, 2010, Vol.118 (2), p.208-208

2010

Volltextzugriff (PDF)

Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers

Gynecologic oncology, 2008, Vol.111 (3), p.487-495

2008

Volltextzugriff (PDF)

Phase I study of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, Fallopian tube, or primary peritoneal cancer patients: An NRG/GOG study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5541-5541

2015

Volltextzugriff (PDF)

A phase I/II trial of ketoconazole + calcitriol [1,25(OH)2D3] in castration-resistant prostate cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5065-5065

2016

Volltextzugriff (PDF)

A phase II evaluation of temsirolimus in combination with carboplatin and paclitaxel followed by temsirolimus consolidation as first-line therapy in the treatment of stage III-IV clear cell carcinoma of the ovary

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.5531-5531

2016

Volltextzugriff (PDF)

P-198: The effect of baseline physical activity on cardiovascular outcomes in patients treated for hypertension with LVH

American journal of hypertension, 2004-05, Vol.17 (S1), p.106A-106A

2004

Volltextzugriff (PDF)

Outcomes of neoadjuvant dual HER2 targeted therapy in HER2 amplified breast cancer in clinical practice: a single institutional experience

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e12096-e12096

2016

Volltextzugriff (PDF)

P-415: Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the life study

American journal of hypertension, 2004-05, Vol.17 (S1), p.186A-186A

2004

Volltextzugriff (PDF)

An evaluation of survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: A Gynecologic Oncology Group experience

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.5534-5534

2013

Volltextzugriff (PDF)

A phase 1 study of the PI3K/mTOR inhibitor PQR309 evaluating safety, pharmacokinetics (PK) and pharmacodynamics (PD) in patients (pts) with advanced solid tumors

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.2560-2560

2016

Volltextzugriff (PDF)

The Effect of a Losartan‐Based Treatment Regimen on Isolated Systolic Hypertension

The journal of clinical hypertension (Greenwich, Conn.), 2002-03, Vol.4 (2), p.101-107

2002

Volltextzugriff (PDF)

A limited access phase I trial of paclitaxel, cisplatin and ABT-888 in the treatment of advanced, persistent, or recurrent carcinoma of the cervix: An NRG/GOG study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5600-5600

2015

Volltextzugriff (PDF)

Abstract AS27: VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: preclinical and phase 1 data by the gynecologic oncology group

Clinical cancer research, 2015-08, Vol.21 (16_Supplement), p.AS27-AS27

2015

Volltextzugriff (PDF)

Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemo-immunotherapy

Clinical cancer research, 2016-10, Vol.23 (8), p.1955-1966

2016

Volltextzugriff (PDF)

A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.5507-5507

2015

Volltextzugriff (PDF)

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the M alignant G erm C ell T umor I nternational C ollaborative

Cancer, 2016-01, Vol.122 (2), p.230-237

2016

Volltextzugriff (PDF)

P-31: Losartan is effective in the treatment of isolated systolic hypertension: data from a multicenter, randomized, double-blind, placebo-controlled, 12-week trial

American journal of hypertension, 2002-04, Vol.15 (S3), p.44A-44A

2002

Volltextzugriff (PDF)

Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors: Results of a Phase II Trial of the Gynecologic Oncology Group

Cancer, 2013-10, Vol.120 (3), p.344-351

2013

Volltextzugriff (PDF)

1 – 25 von 342

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(211)
Mit Volltextzugriff
(295)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(46)
Science & Technology
(37)
Female
(25)
Physical Sciences
(24)
Male
(23)
Science & Technology - Other Topics
(18)
Animals
(17)
Multidisciplinary Sciences
(17)
Multidisciplinary
(15)
Ecg
(14)
Humanities And Social Sciences
(14)
Science
(14)
Biological And Medical Sciences
(12)
Adult
(10)
Physics
(10)
Aged
(9)
Medical Sciences
(9)
Political Science
(9)
War & Defence Operations
(9)
Armed Forces
(8)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Efficacy and safety of bevacizumab in recurrent sex cord‐stromal ovarian tumors: Results of a phase 2 trial of the Gynecologic Oncology Group

A phase I trial of pegylated liposomal doxorubicin (PLD), carboplatin, bevacizumab and veliparib in recurrent, platinum-sensitive ovarian, primary peritoneal, and fallopian tube cancer: An NRG Oncology/Gynecologic Oncology Group study

A phase I study of sequential ipilimumab in the definitive treatment of node positive cervical cancer: GOG 9929

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: Subanalyses of data from a randomized, double-blind, placebo-controlled trial

Corrigendum to: A phase II evaluation of Pazopanib in the treatment of recurrent or persistent carcinosarcoma of the uterus: A Gynecologic Oncology Group Study [Gynecol Oncol 133 (2014) 537–541]

Ezetimibe added to ongoing statin therapy improves LDL-C goal attainment and lipid profile in patients with diabetes or metabolic syndrome

A Phase I Trial of Lenalidomide in Combination with Intermediate Dose Cytarabine (IDC) in Relapsed or Refractory Acute Myeloid Leukemia (AML) Patients

Corrigendum to “A phase II evaluation of mifepristone in the treatment of recurrent or persistent epithelial ovarian, fallopian or primary peritoneal cancer: A gynecologic oncology group study” [Gynecol. Oncol. 116 (2010)]

Associations between p53 overexpression and multiple measures of clinical outcome in high-risk, early stage or suboptimally-resected, advanced stage epithelial ovarian cancers

Phase I study of intraperitoneal IL-12 plasmid formulated with PEG-PEI-cholesterol lipopolymer administered in combination with pegylated liposomal doxorubicin in recurrent or persistent epithelial ovarian, Fallopian tube, or primary peritoneal cancer patients: An NRG/GOG study

A phase I/II trial of ketoconazole + calcitriol [1,25(OH)2D3] in castration-resistant prostate cancer

A phase II evaluation of temsirolimus in combination with carboplatin and paclitaxel followed by temsirolimus consolidation as first-line therapy in the treatment of stage III-IV clear cell carcinoma of the ovary

P-198: The effect of baseline physical activity on cardiovascular outcomes in patients treated for hypertension with LVH

Outcomes of neoadjuvant dual HER2 targeted therapy in HER2 amplified breast cancer in clinical practice: a single institutional experience

P-415: Losartan benefits over atenolol in non-smoking hypertensive patients with left ventricular hypertrophy: the life study

An evaluation of survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum therapy: A Gynecologic Oncology Group experience

A phase 1 study of the PI3K/mTOR inhibitor PQR309 evaluating safety, pharmacokinetics (PK) and pharmacodynamics (PD) in patients (pts) with advanced solid tumors

The Effect of a Losartan‐Based Treatment Regimen on Isolated Systolic Hypertension

A limited access phase I trial of paclitaxel, cisplatin and ABT-888 in the treatment of advanced, persistent, or recurrent carcinoma of the cervix: An NRG/GOG study

Abstract AS27: VTX-2337, a TLR8 agonist, plus chemotherapy in recurrent ovarian cancer: preclinical and phase 1 data by the gynecologic oncology group

Integrative Development of a TLR8 Agonist for Ovarian Cancer Chemo-immunotherapy

A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study

Is adjuvant chemotherapy indicated in ovarian immature teratomas? A combined data analysis from the M alignant G erm C ell T umor I nternational C ollaborative

P-31: Losartan is effective in the treatment of isolated systolic hypertension: data from a multicenter, randomized, double-blind, placebo-controlled, 12-week trial

Efficacy and Safety of Bevacizumab in Recurrent Sex Cord-Stromal Ovarian Tumors: Results of a Phase II Trial of the Gynecologic Oncology Group

Aktive Filter

Suchergebnisse filtern